In addition to MGMT, multiple molecular pathways contribute to resistance, complicating treatment strategies.357 Addressing these mechanisms is crucial for improving GBM therapy, highlighting the need for novel approaches such as combination therapies, MGMT inhibitors, and alternative drug delivery systems to increase TMZ efficacy. Here, MGMT is linked to glioblastoma.